Verily Health

The focus is the business to business products. Lightpath, the chronic care program for diabetes, hypertension and obesity delivered through the Verily Me app, uses AI as what the company calls a self learning system that drives behavior change through rapid feedback loops, with the Violet AI companion in the app and a team of licensed experts in metabolic health, nutrition, behavioral wellness, prescribing and medication adherence, plus health coaches.

The company says Lightpath is built on Verily Pre, which it describes as an AI native platform for analytics, workflow orchestration and AI deployment, and it names Syntax as its clinically informed, FHIR native model. Workbench, a research data environment, and Sightline, a wastewater surveillance program, are sold separately. In Lightpath the clinical team carries value of its own and the AI personalizes and routes the program, so the model is the engine of a core module rather than the whole product.

The oversight structure is described and its escalation rule is not. Lightpath pairs AI driven coaching with licensed experts in metabolic health, nutrition, behavioral wellness, prescribing and medication adherence, plus health coaches, and the company's launch material says agents triage members and escalate them to the licensed clinical team when clinically indicated, with clinicians and coaches at the center and AI as a feature.

What is not published is the threshold: what makes an escalation clinically indicated, what the Violet companion does with a question it should not answer, how quickly a clinician responds, and what happens when a member who needed a clinician stayed with automated support.

The products are named and the technology behind Lightpath is described only in general terms. The company names Syntax as its clinically informed, FHIR native model and says Lightpath is built on Verily Pre, its AI native platform, and it describes Lightpath's AI as a self learning system driving behavior change through rapid feedback loops, with a Violet AI companion in the app.

Nothing states whether Syntax runs in Lightpath, which model powers Violet or the routing, whether any model is licensed from a third party, what the models were trained on, or how versions are released and communicated.

Who else receives Lightpath member data between the member and the AI's output is not established. No hosting provider, subprocessor list or model provider is named for the Violet companion or the routing, and no statement says whether Syntax, the company's own model, or a third party model is in the path.

The April 2026 independence announcement names NVIDIA tools and a Samsung Galaxy Watch 8 integration and Alphabet as a significant minority investor, without saying what data, if any, reaches them. The Lightpath privacy policy, issued by Verily Health Inc., may name recipients.

The research platforms have named customers and Lightpath has no published outcomes. Workbench supports the NIH All of Us Research Program, which the company says serves more than 21,500 researchers, and the company has also named the Michael J. Fox Foundation and Helix as users; that is scale of use for research infrastructure, not evidence that the care program works.

For Lightpath, the care program itself, the solutions page gives no outcome figure and the company publishes no study of the program; it reached open enrollment in January 2026. The company has published research insight pieces on its behavioral approach to nutrition change, which are not outcome evaluations as far as their titles show.

Verily publishes categorical commitments in member facing language: consent to care is obtained explicitly before the care team retrieves records, access is limited to the uses a member has consented to, a zero tolerance policy applies to misuse or improper sharing of health information, collection is limited by design to what is necessary, and data is encrypted in transit and at rest. Records are retrieved by an affiliated licensed provider group rather than by the technology company.

The retention schedule and the AI questions are left open. There is no statement of what is kept from conversations with the Violet companion or from meal photographs, who can read those logs, or whether member records and interactions are used to develop or tune models. No safety engineering is published: nothing on guardrails for the companion or how a safety event is handled. The Lightpath privacy policy, issued by Verily Health Inc., may set out retention and training terms.

Records are retrieved for Lightpath by the company's affiliated licensed provider group after the member explicitly consents to care, which places retrieval inside a clinical relationship governed by HIPAA rather than a patient directed transfer outside it, and the company publishes member facing privacy commitments on consent, use limitation and encryption.

Where the program is sold through health plans and employers, a business associate relationship with the plan would be expected; that is an inference, and no business associate agreement, tier or subcontractor terms are published. Records held by a provider group are medical records with retention requirements measured in years, so a member's deletion request will be limited by rules that protect them, which the member materials do not explain. Verily Health Inc. issues the Lightpath privacy policy, and its terms may spell out the HIPAA status.

The company names certification to ISO/IEC 27001 with the ISO/IEC 27017 and 27018 cloud standards, which are recognized audits of how it operates security, on a data security and trust page, and describes privacy by design, encryption in transit and at rest, access controls and continuous monitoring. No certificate, scope statement, SOC 2 report, penetration test summary or vulnerability reporting route is published, so the artifacts are not retrievable without asking.

The company became independent of Alphabet in April 2026 and now operates as Verily Health Inc.; certifications are held by legal entities and cover defined scopes, and nothing published shows that they are current, held in the operating entity's name after independence, or cover Lightpath.

No device claim is made for the business to business products, and no regulatory position is stated. Lightpath is a care program delivered by licensed clinicians with AI coaching and routing, Workbench is research infrastructure, and Sightline analyzes wastewater rather than identified individuals.

What governs the care program is professional licensure of the affiliated provider group's clinicians state by state, ordinary prescribing law for the metabolic medications it manages, and benefit design where it is sold through health plans; those govern the practice, and the company does not state them as a position on the software.

The boundary sits at the routing layer: software that decides whether a member reaches a clinician stays outside device regulation while a clinician can review its basis, and nothing published describes what the escalation presents to the clinician who receives it.

Governance is named as a product function and no evaluation of how Lightpath's AI behaves is published. The home page describes Verily Pre as the platform for analytics, workflow orchestration, AI deployment and governance, which is a statement about what the platform offers customers rather than how the company governs or tests its own models. No bias evaluation, subgroup performance, governance framework, model update policy or outside review is published for Lightpath.

The decision that matters is allocation: agents route members either to automated coaching or to the licensed clinical team, and cardiometabolic care has well documented differences in access, diagnosis and treatment across populations, so a routing model learning from past engagement could reproduce them without any member noticing.

Nothing covers the Violet companion's behavior either: what it declines to answer, how it handles a question that should prompt escalation, or how it performs across health literacy levels and languages.

What Verily publishes is a clinical structure around the AI, not a commitment behind it. The company's Lightpath material describes AI driven coaching and feedback alongside licensed experts in metabolic health, nutrition, behavioral wellness, prescribing and medication adherence, and describes members being escalated to that clinical team when clinically indicated, so a clinician can review and override the program's direction.

No warranty, indemnity or remediation commitment attached to an output is published, and no error rate exists for the routing that decides who reaches a clinician or for the Violet companion, which answers members' questions in the app with no clinician between the answer and the member. A member who believes they should have been escalated has no stated route to raise it with the company.

Inbound retrieval is described with its limits, through named consumer frameworks and unnamed exchanges. With a member's consent, the affiliated provider group retrieves records from multiple health systems and health information exchanges and consolidates medications, conditions, procedures, immunizations and test results into a longitudinal profile, and the app reads data from Apple Health and Google Health Connect; the April 2026 announcement adds Samsung Galaxy Watch 8.

Members are told to expect around nine years of history on average, with completeness varying by provider participation and data type. The company names Syntax, its model, as FHIR native. The exchanges and health systems are not named, and nothing describes a return path: whether care team notes, escalations or outcomes reach the member's own physician or record.

Lightpath is a cloud delivered service with a mobile app, and its product pages name no hosting location, region, tenancy model or subprocessor list. The company names the ISO/IEC 27017 and 27018 cloud standards among its certifications, which says it operates and has been audited as a cloud service, not where data rests. The Lightpath privacy policy, issued by Verily Health Inc., may state a storage location.

The company became independent of Alphabet in April 2026, with Alphabet remaining a significant minority investor, and nothing published says what infrastructure the company now runs on or whether any dependency on the former parent continues under an agreement. The research environment, Workbench, has its own governance and access model, separate from Lightpath's.

The member's cost is published and the buyer's is not. The company's member facing materials say the app is free to download with no insurance copay, standard features are free, the enhanced program is reached through an insurer or employer as a benefit, the company will not bill the member's insurance, and using the app will not affect coverage, so a member can settle their own exposure without contacting anyone.

The programs' buyers are health plans, employers and pharmacy benefit managers, and for them nothing is published: no rate, per member price, minimum, contract term or risk sharing arrangement. How the program is bought is discoverable, as a sponsored benefit, but a benefits leader cannot size the cost before a conversation. Workbench and Sightline are contracted separately with research and public health organizations.

Lightpath's coverage is stated clearly, with entry criteria, and nothing published validates it yet. The program covers type 1 diabetes, type 2 diabetes with A1c above 8 percent, hypertension above 130/80, obesity and weight loss, and related comorbidities, delivered through the Verily Me app to members whose health plan or employer sponsors it. The company's Lightpath research insights piece (25 November 2025) describes internal design research, a 10 day meal logging diary study with 21 participants managing type 2 diabetes, obesity or hypertension and interviews with 9 registered dietitians, which shaped its nutrition coaching approach; it reports no clinical outcome such as A1c, blood pressure or weight change and is not presented as peer reviewed. No outcome by condition or entry criterion is published.

Workbench and Sightline serve research and public health settings, apart from Lightpath.

Coverage stated clearly with nothing validating it.